Personalized vaccine trial aims to turn immune system against cancer
NCT ID NCT05741242
Summary
This study is testing a personalized vaccine designed to teach a patient's own immune system to recognize and attack their specific cancer. It is for people with certain solid tumors, including pancreatic cancer and glioblastoma, who have limited treatment options. The main goals are to see if the vaccine is safe and if it can help control the cancer and help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anna Gattani MD PC
New York, New York, 10028, United States
-
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, 33140, United States
-
Precision NextGen Oncology & Research Center
Beverly Hills, California, 90212, United States
-
Quest Clinical Research
San Francisco, California, 94115, United States
-
St. Louis Cancer Care
Bridgeton, Missouri, 63044, United States
Conditions
Explore the condition pages connected to this study.